Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan · Delayed Price · Currency is TWD 32.75
-0.10 (-0.30%)
Oct 20, 2026, 1:30 PM CST
Senhwa Biosciences Market Cap
Senhwa Biosciences has a market cap or net worth of 2.94 billion as of October 20, 2026. It is the 25,962nd most valuable company in the world and the 1,419th biggest in Taiwan. Its market cap has decreased by 25.00% in one year.
Market Cap
2.94B
Enterprise Value
2.32B
Revenue
1.05M
Global Rank
Country Rank
#1,419 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 4, 2014, Senhwa Biosciences's market cap has decreased from 6.81B to 2.94B, a decrease of -56.89%. That is a compound annual growth rate of -6.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 2.93B | -25.40% |
| Dec 31, 2025 | 3.92B | 1.15% |
| Dec 31, 2024 | 3.88B | -14.54% |
| Dec 29, 2023 | 4.54B | -11.69% |
| Dec 30, 2022 | 5.14B | -44.90% |
| Dec 30, 2021 | 9.33B | -53.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmosa Biopharm | 3.61B |
| SYN-TECH Chem. & Pharm. | 3.42B |
| Great Novel Therapeutics Biotech & Medicals | 3.33B |
| Shine-On BioMedical | 3.30B |
| BioGend Therapeutics | 3.28B |
| Intech Biopharm | 3.19B |
| Sagittarius Life Science | 3.16B |
| Energenesis Biomedical CO.,LTD. | 2.87B |